Inorganic nanosystems for therapeutic delivery: status and prospects
about
Organic chemistry meets polymers, nanoscience, therapeutics and diagnosticsMagnetosomes, biogenic magnetic nanomaterials for brain molecular imaging with 17.2 T MRI scanner.Dual-Modality Positron Emission Tomography/Optical Image-Guided Photodynamic Cancer Therapy with Chlorin e6-Containing NanomicellesEfficient up-conversion in Yb:Er:NaT(XO4)2 thermal nanoprobes. Imaging of their distribution in a perfused mouse.NaGd(MoO4)2 nanocrystals with diverse morphologies: controlled synthesis, growth mechanism, photoluminescence and thermometric propertiesVirus-Surface-Mimicking Surface Clustering of AuNPs onto DNA-Entrapped Polymeric Nanoparticle for Enhanced Cellular Internalization and Nanocluster-Induced NIR Photothermal Therapy.Merging the best of both worlds: hybrid lipid-enveloped matrix nanocomposites in drug delivery.Silica-based nanoparticles: a versatile tool for the development of efficient imaging agents.No king without a crown--impact of the nanomaterial-protein corona on nanobiomedicine.Inorganic nanovectors for nucleic acid delivery.Chemistry of Mesoporous Organosilica in Nanotechnology: Molecularly Organic-Inorganic Hybridization into Frameworks.Recent advances in the use of nanoparticles for allergen-specific immunotherapy.Exosome encased spherical nucleic acid gold nanoparticle conjugates as potent microRNA regulation agentsAdvances in Anticancer Protein Delivery Using Micro-/ Nanoparticles.LHRH-PE40 fusion protein tethered silica nanorattles for imaging-guided tumor-specific drug delivery and bimodal therapy.Stimuli-disassembling gold nanoclusters for diagnosis of early stage oral cancer by optical coherence tomography.Few-Layered Black Phosphorus: From Fabrication and Customization to Biomedical Applications.Chitosan-ceramide coating on gold nanorod to improve its physiological stability and reduce the lipid surface-related toxicity.Biomedical applications of gold nanorod-based multifunctional nano-carriersDesign, synthesis, characterisation and in vitro studies of hydrophilic, colloidally stable, 64Cu(ii)-labelled, ultra-small iron oxide nanoparticles in a range of human cell linesComparison of different silica microporous structures as drug delivery systems for in vitro models of solid tumors
P2860
Q26738941-66183E2B-E997-4EBA-999F-76E7EC2C25C2Q30891547-DD1C3957-3277-4F40-BD20-11478C1D0D8EQ36085944-801EB9A7-ECB7-441D-B39B-42CCB1834378Q36380386-C3757EE9-2A6A-4CCE-80D7-64D43BB10D22Q37163773-56866ACE-EE3F-4B02-943F-C85D2DC2FB89Q37279372-6FE09257-971A-4119-B238-3B93E0CF5018Q38150118-40EBEE36-E9D4-4995-AF77-E7164A5CA427Q38269215-9E6DDC25-2FD4-4F66-A5C3-78591ABF60F2Q38364473-24ADD5B5-A579-43C7-BF7A-967B162ED34DQ38383483-D1E5AC91-681F-49D3-BA25-7CBF876FBFA1Q38758605-A23EC6B0-1CA9-4C03-8D91-5ED2946EF86BQ38802840-6DBAF6DD-C6FB-4599-B277-A7CDCE5A6153Q39084227-A4C1DED9-FAF1-49F5-8E1E-405F2EE91DA8Q39092873-9A9AD0FA-264F-4F37-927B-3666E0566CCEQ39121585-926A29C0-174C-4E16-9EF5-DF10A00CC357Q48109188-AB4AD690-AE3D-4317-8F46-09A985BFDA37Q50014441-3B26FD45-485C-45F9-B8E2-C33374D8EC2EQ51197751-2A380A23-1046-491B-BC5D-C648770AEE73Q57348026-F476F244-36EA-4FFA-9523-A4F6A54DAC44Q57376692-2C2213D2-B028-439E-BF63-12AC006C6B57Q57650982-1E6D1953-8C0A-406E-AA1F-BCBBB7DEB7ED
P2860
Inorganic nanosystems for therapeutic delivery: status and prospects
description
2013 nî lūn-bûn
@nan
2013 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Inorganic nanosystems for therapeutic delivery: status and prospects
@ast
Inorganic nanosystems for therapeutic delivery: status and prospects
@en
Inorganic nanosystems for therapeutic delivery: status and prospects
@nl
type
label
Inorganic nanosystems for therapeutic delivery: status and prospects
@ast
Inorganic nanosystems for therapeutic delivery: status and prospects
@en
Inorganic nanosystems for therapeutic delivery: status and prospects
@nl
prefLabel
Inorganic nanosystems for therapeutic delivery: status and prospects
@ast
Inorganic nanosystems for therapeutic delivery: status and prospects
@en
Inorganic nanosystems for therapeutic delivery: status and prospects
@nl
P2093
P2860
P3181
P1476
Inorganic nanosystems for therapeutic delivery: status and prospects
@en
P2093
Chang Soo Kim
David Solfiell
Gülen Yesilbag Tonga
P2860
P3181
P356
10.1016/J.ADDR.2012.08.011
P407
P577
2013-01-01T00:00:00Z